Sunday, May 11, 2025 1:00:27 AM
How many IFR per year are approved by NHS/NICE...
Look it up, depending on how you ask the question to chatgpt/grok, it will be either:
46 IFR PER YEAR!!! (for all solid tumor)
26 IFR per year!!! (for specialized services)
(share between different drugs/treatment)
Now do the math...
"Oh wait, there is a chance they fund it fully" you are going to say...
Do the math at 200k - 250k per treatment...
Multiply by 100 patient= 20 Million.
1000 patient= 200 Million
3000 patient= 600 Million (UK new GBM case per year)
Right now the most $ a drug receive by NHS is ~400 ish million. So I guess it could be possible for NWBO in the future.
(~2000 patient)
Hopefully they will fully fund it for GBM only, because it "could be possible" or "within their budget"
But no way they will ever be able to fund it for ALL solid tumor, or something past 10 000 patient... (which is 2 or 2.5 billion depending if the cost is 200, or 250k per treatment...)
Will see...
Since the RFI status might change to fully funded, hopefully they can change it to GBM, and have IFR for the rest of all solid cancer.
So yes, if IFR remain, it is a bad news.
If it change to fully funded for GBM, then we are good.
As for:
-> Lots of people are going to pay 200k for themselves or via fundraiser.... Look at the statistics on that per year... Not good either...
Look it up, depending on how you ask the question to chatgpt/grok, it will be either:
46 IFR PER YEAR!!! (for all solid tumor)
26 IFR per year!!! (for specialized services)
(share between different drugs/treatment)
Now do the math...
"Oh wait, there is a chance they fund it fully" you are going to say...
Do the math at 200k - 250k per treatment...
Multiply by 100 patient= 20 Million.
1000 patient= 200 Million
3000 patient= 600 Million (UK new GBM case per year)
Right now the most $ a drug receive by NHS is ~400 ish million. So I guess it could be possible for NWBO in the future.
(~2000 patient)
Hopefully they will fully fund it for GBM only, because it "could be possible" or "within their budget"
But no way they will ever be able to fund it for ALL solid tumor, or something past 10 000 patient... (which is 2 or 2.5 billion depending if the cost is 200, or 250k per treatment...)
Will see...
Since the RFI status might change to fully funded, hopefully they can change it to GBM, and have IFR for the rest of all solid cancer.
So yes, if IFR remain, it is a bad news.
If it change to fully funded for GBM, then we are good.
As for:
-> Lots of people are going to pay 200k for themselves or via fundraiser.... Look at the statistics on that per year... Not good either...
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
